CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 231 enrolled
Drug / intervention
An innovative 3-lead wireless water resistant Holter device +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04723355
NCT04723355N/ACompleted

A Comparative Study of the Findings of Dynamic Electrocardiography (Holter System) Using the an Innovative 3-lead Wireless Water Resistant Device and a Conventional Device

Hospital Israelita Albert Einstein·interventional·Posted Jan 25, 2021·Updated Oct 24, 2024

In Brief

A clinical study evaluating An innovative 3-lead wireless water resistant Holter device and A conventional device for Cardiac Arrhythmia. Completed, enrolled 231 participants across 1 site.

Detailed Summary

Holter monitoring is one of the most widely used diagnostic methods to detect cardiac arrhythmias. Newer Holter monitors may provide some advantages over the more traditional ones. This study will compare the findings of a Holter exam using an innovative 3-lead wireless water resistant device with a conventional device.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesBrazil

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJan 25, 2021
Enrollment StartJan 26, 2021
Primary CompletionNov 16, 2021
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 5.4 years ago

Interventions

An innovative 3-lead wireless water resistant Holter devicedevice

The participant will use the innovative 3-lead wireless water resistant Holter device simultaneously with the conventional Holter device for 24 hours.

A conventional devicedevice

The participant will use the innovative 3-lead wireless water resistant Holter device simultaneously with the conventional Holter device for 24 hours.